Showing 1 of 1 PublicationsLicensing drugs for diabetesLehman R, Yudkin JS, Krumholz H. Licensing drugs for diabetes. The BMJ 2010, 341: c4805. PMID: 20819887, DOI: 10.1136/bmj.c4805.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsCardiovascular DiseasesDiabetes Mellitus, Type 2Drug ApprovalHumansHypoglycemic AgentsRosiglitazoneSafety-Based Drug WithdrawalsThiazolidinedionesConceptsSurrogate end pointsEnd pointRobust evidenceDiabetesDownload Full List
Licensing drugs for diabetesLehman R, Yudkin JS, Krumholz H. Licensing drugs for diabetes. The BMJ 2010, 341: c4805. PMID: 20819887, DOI: 10.1136/bmj.c4805.Peer-Reviewed Original ResearchCitationsAltmetricMeSH Keywords and ConceptsMeSH KeywordsCardiovascular DiseasesDiabetes Mellitus, Type 2Drug ApprovalHumansHypoglycemic AgentsRosiglitazoneSafety-Based Drug WithdrawalsThiazolidinedionesConceptsSurrogate end pointsEnd pointRobust evidenceDiabetes